Developing the pharmaceutical product offering

Optimise the product profile for your target markets

Active compounds are developed into patented products for testing in clinical trials and investigational new drug applications are made with relevant regulatory bodies for approval. At this stage (around Phase III), marketing measures are developed to support the pharmaceutical product offering, covering such areas as the target product profile, market forecasting and preliminary positioning.

Key questions which need to be answered at this stage include:

  • What is the best way to design clinical trials?
  • What is the market opportunity?
  • What is the likely size of the market segment? 
  • What should the product be named?
  • What should be the general positioning for this product?

Our custom pharmaceutical market research offerings include:

  • Clinical trial design evaluation
  • Market opportunity assessment
  • Forecasting
  • Name testing
  • Market positioning

Product development resources:

rare-diseases-case-study-1_284x348

Case study

How a combined qual quant approach provided our client with integral insights for continued product development in the HIV space.

Learn more

NPD guide

Guide

Five steps to creating a research programme to support an effective pharma brand launch.


Download

AI treatment case study

Case study

How we evaluated the potential for an existing AI product to treat a rare disease.



Learn more